EP 1017664 A1 20000712 - C3A RECEPTOR LIGANDS
Title (en)
C3A RECEPTOR LIGANDS
Title (de)
C3A-REZEPTORLIGANDEN
Title (fr)
LIGANDS POUR RECEPTEURS DE C3A
Publication
Application
Priority
- US 9820051 W 19980923
- US 5975097 P 19970923
- US 6994997 P 19971217
Abstract (en)
[origin: WO9915490A1] Novel C3A ligands are provided. Methods of using the present compunds to treat immune and inflammation disease are also provided.
IPC 1-7
IPC 8 full level
A61K 31/19 (2006.01); A61K 31/198 (2006.01); A61K 31/381 (2006.01); A61K 31/4164 (2006.01); A61K 31/4406 (2006.01); A61K 31/4409 (2006.01); A61K 31/443 (2006.01); A61K 31/47 (2006.01); A61K 31/472 (2006.01); A61P 11/00 (2006.01); A61P 13/12 (2006.01); A61P 17/06 (2006.01); A61P 19/06 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 37/06 (2006.01); A61P 43/00 (2006.01); C07C 279/14 (2006.01); C07C 311/19 (2006.01); C07D 211/14 (2006.01); C07D 211/98 (2006.01); C07D 213/81 (2006.01); C07D 213/82 (2006.01); C07D 215/06 (2006.01); C07D 215/36 (2006.01); C07D 217/04 (2006.01); C07D 233/84 (2006.01); C07D 317/58 (2006.01); C07D 333/22 (2006.01); C07D 333/34 (2006.01); C07D 405/12 (2006.01)
CPC (source: EP)
A61P 11/00 (2017.12); A61P 13/12 (2017.12); A61P 17/06 (2017.12); A61P 19/06 (2017.12); A61P 25/28 (2017.12); A61P 29/00 (2017.12); A61P 37/06 (2017.12); A61P 43/00 (2017.12); C07C 279/14 (2013.01); C07C 311/19 (2013.01)
Citation (search report)
See references of WO 9915490A1
Designated contracting state (EPC)
BE CH DE ES FR GB IT LI NL
DOCDB simple family (publication)
WO 9915490 A1 19990401; CA 2303883 A1 19990401; EP 1017664 A1 20000712; JP 2001517648 A 20011009
DOCDB simple family (application)
US 9820051 W 19980923; CA 2303883 A 19980923; EP 98950673 A 19980923; JP 2000512802 A 19980923